Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.

Digestive diseases (Basel, Switzerland) - 1 Jan 2003

Schultz Michael, Schölmerich Jürgen, Rath Heiko C

Abstract excerpt

Inflammatory bowel diseases (IBD), commonly referred to as Crohn's disease and ulcerative colitis are chronic aggressive disorders which share many similarities concerning pathomechanism and clinical course, but have very distinct features. Both entities are mainly located in areas with high bacterial concentrations, such as the terminal ileum and cecum in Crohn's disease and the rectum in ulcerative colitis. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Bacteria
Share to Colitis, Ulcerative

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Crohn Disease

Share to Digestive System

Share to Genetic Predisposition to Disease

Share to Intestinal Mucosa

Share to Probiotics

Source

Identifiers

PMID: 14571109
DOI: 10.1159/000073243

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.PMID 14571109Read ↗

The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and ProbioticsSemantic proximity Read ↗

Gut microbiome–based therapeutics in inflammatory bowel diseaseSemantic proximity Read ↗

Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel diseaseSemantic proximity Read ↗

Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and UtilitySemantic proximity Read ↗

Role of commensal gut bacteria in inflammatory bowel diseasesSemantic proximity Read ↗

Inflammatory bowel disease: new insights into pathogenesis and treatment.Semantic proximity Read ↗

Antibiotic Therapy for Active Crohn’s Disease Targeting Pathogens: An Overview and UpdateSemantic proximity Read ↗

Inflammatory bowel disease, gut bacteria and probiotic therapySemantic proximity Read ↗

Inflammatory bowel disease pathogenesis: therapeutic implications.Semantic proximity Read ↗

Bacterial imbalance and gut pathologies: Association and contribution of E. coli in inflammatory bowel diseaseSemantic proximity Read ↗

Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New ApproachesSemantic proximity Read ↗

Microbial-host interactions in inflammatory bowel diseases and experimental colitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.